Resource Center
Explore Resource Types
Focused Solutions
Biologics
Make advancements with precision biologics tools, designed to enhance your therapeutic approaches encompassing monoclonal antibodies, recombinant proteins, vaccines, and targeted next-generation cell and gene therapies.
Cell and Gene Therapy
The recent success of cell and gene therapies has paved the way for the next generation of advanced therapeutics. While challenges remain, cell and gene therapy research is seeing a transformational shift in the way that novel modalities, such as CAR-T, CRISPR, and vectors, are developed and delivered.
Disease Research
New drug modalities and targets are enabling us to live longer and healthier lives— but their development is grounded on a deep understanding of disease onset and progression.
Drug Development
The process of drug development comprises all the activities involved in bringing a new drug to market once a lead compound has been identified.
Functional Genomic Screening Services
Identify and characterize drug discovery targets with functional genomic screening services. Offering CRISPR knockout, CRISPR activation, CRISPR inhibition, dual screening and RNAi technologies
Integrated Lab Automation
From cellular screening and imaging applications to high-throughput screening and genomics-based applications, custom explorer™ G3 integrated workstations
Physiological Model Solutions
Drug discovery endeavors require a deep understanding of biological systems and their response to potential therapeutics.
Precision Medicine Research
Countless diseases, especially cancer, are highly heterogenous in nature which means a one-drug-fitsall approach isn’t practical for treating or fighting these diseases effectively.
Small Molecule Drug Discovery
With decades of experience in drug discovery driven by strong customer relationships, Revvity has developed an excellent product portfolio of drug discovery tools for complete solutions serving all parts of the discovery workflow.
All Resources
Filters
85 - 96 of 1380 Results
Testing reportedly healthy individuals for a panel of 59 medically actionably genes: are 59 genes enough?
Non-Invasive Prenatal Screening by Vanadis LifeCycle® Platform
Ultrarapid Whole Genome Sequencing Facilitates Early Definitive Diagnosis of Rare Genetic Disorders
Whole Genome Sequencing as a Screening Tool in Healthy Population: Lesson learned from 110 cases
Case Presentation: Co-segregation of a Rare GLA Variant of Uncertain Significance within Two Multiplex Families Facilitates Variant Reclassification to Pathogenic
Unveiling Noncoding DMD Variants: Synergizing RNA Sequencing and DNA Sequencing for Enhanced Molecular Diagnosis
Genomic breakpoint analysis facilitates identification of complex rearrangements and re-classification of non-tandem duplications in the DMD gene: Implications for prenatal testing and new therapeutics.
Identification of Multiple Diagnoses in Pediatric Patients through Genome Sequencing
Comparison of GLA variant profile in newborn screening confirmatory testing and diagnostic testing for Fabry disease
Recognizing the Promise and Potential Pitfalls of Genomic Medicine Through Routine Rapid Whole Genome Sequencing
Advance your research on neurodegenerative diseases
Whole Genome Sequencing - Secondary Findings - Pharmacogenomics
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.